The DOI matches its Crossref record.
IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB
Abstract
Recombinant human IL-11 (rhIL-11) is an anti-inflammatory cytokine that can reduce the production of inflammatory mediators such as TNF-alpha, IL-1beta, IL-12, IL-6, and nitric oxide. Inhibition of proinflammatory cytokine production from activated macrophages was associated with a reduction in the levels of LPS-induced TNF-alpha, IL-1beta, IL-6, and IL-12 p40 mRNA. Analysis of rhIL-11 effects on transcription factors that activate proinflammatory cytokines demonstrated that the level of LPS-induced NF-kappaB binding activity in the nucleus of rhIL-11-treated peritoneal macrophages was significantly reduced. The block to NF-kappaB nuclear translocation correlated with the ability of rhIL-11 to maintain or increase protein levels of the inhibitors of NF-kappaB, IkappaB-alpha, and IkappaB-beta following LPS treatment. Furthermore, rhIL-11-treatment of LPS macrophages resulted in significant elevation of IkappaB-alpha and IkappaB-beta mRNA levels. These results suggest that the anti-inflammatory activity of rhIL-11 is mediated in part by inhibition of NF-kappaB-dependent transcriptional activation. Furthermore, these studies demonstrate for the first time the regulation of IkappaB-beta by an anti-inflammatory cytokine. Given the finding that inappropriate activation of NF-kappaB contributes to multiple inflammatory conditions, the ability of rhIL-11 to inhibit the binding activity of this pleiotropic transcription factor indicates that rhIL-11 has therapeutic potential in a wide range of diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Hill, G. R., & Ferrara, J. L. M. (2000) · Blood · doi:10.1182/blood.v95.9.2754.009k25_2754_2759 · Cited by 715
Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease
Wang, Y., Wang, Y. P., Zheng, G., Lee, V. W. S., Ouyang, L., Chang, D. H. H., Mahajan, D., Coombs, J., Wang, Y. M., Alexander, S. I., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002275 · Cited by 369
Cooke, K. R., Hill, G. R., Crawford, J. M., Bungard, D., Brinson, Y. S., Delmonte, J., & Ferrara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4285 · Cited by 335
Toll‐like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators
Bsibsi, M., Persoon‐Deen, C., Verwer, R. W. H., Meeuwsen, S., Ravid, R., & Van Noort, J. M. (2006) · Glia · doi:10.1002/glia.20328 · Cited by 297
Hill, G. R., Cooke, K. R., Teshima, T., Crawford, J. M., Keith, J. C., Brinson, Y. S., Bungard, D., & Ferrara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3132 · Cited by 268
The role of IL-11 in immunity and cancer
Xu, D. H., Zhu, Z., Wakefield, M. R., Xiao, H., Bai, Q., & Fang, Y. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.004 · Cited by 134
Molecular basis of the cell specificity of cytokine action
Ishihara, K., & Hirano, T. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00321-x · Cited by 122
IL-11 Activates Human Endothelial Cells to Resist Immune-Mediated Injury
Mahboubi, K., Biedermann, B. C., Carroll, J. M., & Pober, J. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3837 · Cited by 80
The Immune Response to Respiratory Syncytial Virus Infection: Friend or Foe?
Welliver, R. C. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8033-2 · Cited by 46
Metadata
- Authors
- Trepicchio, W. L., Wang, L., Bozza, M., & Dorner, A. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-12-01
- Volume
- 159
- Issue
- 11
- Pages
- 5661-5670
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1952386736
- Cited by
- 204
- References
- 0
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.